Xu, Heping
Queen's University Belfast,
United Kingdom
2025 Rank: 84,997
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Immunology
Rank in SubField 1: 418 out of 81,681 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84,997 | 88,920 |
| Total Cites | 845 | 914 |
| H-index | 15 | 16 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 147 | 153 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 514 | 548 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 641 | 666 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
7.55%
|
|
Xu, Heping
Queen's University Belfast,
United Kingdom
2024 Rank: 107,920
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Immunology
Rank in SubField 1: 551 out of 77,284 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107,920 | 102,944 |
| Total Cites | 730 | 816 |
| H-index | 13 | 14 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 129 | 143 |
| Number of Single+First+Last Authored Papers | 86 | 86 |
| Total Cites to Single+First+Last Authored Papers | 428 | 488 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 612 | 634 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.29 |
| Self-Citation Percentage |
10.54%
|
|
Xu, Heping
School of Medicine, Dentistry and Biomedical Sciences,
United Kingdom
2023 Rank: 91,426
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Immunology
Rank in SubField 1: 498 out of 72,989 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91,426 | 99,484 |
| Total Cites | 689 | 770 |
| H-index | 14 | 14 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 156 | 165 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 417 | 470 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 551 | 568 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.36 |
| Self-Citation Percentage |
10.52%
|
|
Xu, Heping
School of Medicine, Dentistry and Biomedical Sciences,
United Kingdom
2022 Rank: 83,831
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Immunology
Rank in SubField 1: 458 out of 69,077 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83,831 | 87,164 |
| Total Cites | 705 | 784 |
| H-index | 14 | 14 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 156 | 166 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 419 | 454 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 560 | 594 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.32 |
| Self-Citation Percentage |
10.08%
|
|
Xu, Heping
Queen's University Belfast,
United Kingdom
2021 Rank: 102,580
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Immunology
Rank in SubField 1: 574 out of 65,331 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102,580 | 107,455 |
| Total Cites | 888 | 1,010 |
| H-index | 16 | 17 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 213 | 229 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 552 | 614 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 702 | 747 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.35 |
| Self-Citation Percentage |
12.08%
|
|
Xu, Heping
Queen's University Belfast,
United Kingdom
2020 Rank: 119,651
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Immunology
Rank in SubField 1: 626 out of 52,338 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 119,651 | 107,779 |
| Total Cites | 548 | 651 |
| H-index | 11 | 13 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 150 | 171 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 360 | 424 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 421 | 449 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.45 |
| Self-Citation Percentage |
15.82%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.